Quantcast
Browsing all 5564 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

First in Asia to Develop Liver Cancer Registry Through Collaborations Among...

  SINGAPORE National Cancer Centre Singapore (NCCS), Singapore Clinical Research Institute (SCRI) and IMS Health (NYSE:IMS) will collaborate to develop its first Liver Cancer or Hepatocellular...

View Article


Image may be NSFW.
Clik here to view.

New International University Alliance to Address Global Challenges with...

  LONDON Arizona State University, King’s College London and UNSW Australia have come together to form the PLuS Alliance, a new partnership to help find research-led solutions to global challenges and...

View Article


Image may be NSFW.
Clik here to view.

Takeda Reports Results for Three Quarters (April-December) of...

  OSAKA, Japan Takeda Pharmaceutical Company Limited (TOKYO:4502): Results of April to December period reaffirms full-year management guidance Underlying revenue +3.8% year-to-year (reported revenue...

View Article

Image may be NSFW.
Clik here to view.

武田薬品:2015年度第3四半期(4-12月期)の連結業績について

  大阪 (ビジネスワイヤ) — 武田薬品工業株式会社 (東証:4502): 第3四半期(4-12月期)連結業績に照らし、年間マネジメントガイダンスを維持 売上収益の実質的な成長は、米国および新興国市場における力強い伸長により、対前年度+3.8%(財務ベースでは対前年度+4.0%の13,933億円)...

View Article

Image may be NSFW.
Clik here to view.

LCT Receives Ethics Approval for Phase IIb Parkinson’s Trial

  SYDNEY & AUCKLAND, New Zealand Living Cell Technologies (ASX: LCT) (OTCQX: LVCLY) has received approval from the Northern A Health and Disability Ethics Committee for the Phase IIb clinical...

View Article


Image may be NSFW.
Clik here to view.

ENYO Pharma:完成总额2200万欧元的第一轮融资

  法国里昂 (美国商业资讯)–日前,ENYO Pharma完成了总额2200万欧元的A轮融资。该项投资旨在帮助这家致力于开发用于治疗急慢性病毒感染药物的生物制药公司更快地开展其乙型肝炎临床项目。 这项由Sofinnova Partners携手Morningside和InnoBio完成的投资将帮助ENYO...

View Article

Image may be NSFW.
Clik here to view.

ENYO Pharma announces closing of a €22 million funding round

  LYON, France ENYO Pharma, a biopharmaceutical company focused on developing treatments for acute and chronic viral infections, today announced that it has secured a €22 million Series A financing...

View Article

Image may be NSFW.
Clik here to view.

NAMSA宣布剥离其无菌保障产品部门

  俄亥俄州诺斯伍德 (美国商业资讯) — 世界领先的医学研究组织(MRO®) North American Science Associates, Inc. (NAMSA)今天宣布达成确定性协议,剥离其从事生物学和化学指示剂业务的无菌保障产品部门。致力于向患者、医疗照护人员和其他医疗保健提供者交付创新感染预防产品的Crosstex International, Inc....

View Article


Image may be NSFW.
Clik here to view.

武田公布2015财年三个季度(4-12月)的业绩,再次确认全年的管理层指引

  日本大阪 (美国商业资讯) — 武田药品工业株式会社(TOKYO:4502): 4月至12月的结果再次肯定管理层全年指引 基础营收年增长率为3.8%(报告的营收增长率为4.0%,至13,933亿日元),由美国和新兴市场的强劲业绩所主导 基础核心收益年增长率为1.5%(运营利润 -15.9%,至1,675亿日元) 基础核心EPS年增长率 为17.3%(报告的EPS增长率为43%,至145日元)...

View Article


Image may be NSFW.
Clik here to view.

康龙化成收购Quotient Bioresearch

  北京 (美国商业资讯)–康龙化成是一家全方位一体化合同研究组织(CRO),面向药企和生物技术研发提供实验室和制造服务,该公司今天宣布收购Quotient Bioresearch (Quotient)。Quotient是一家总部位于英国的合同研究组织,拥有200多位员工,专注于整合放射化学与代谢。该专项技能的一部分来源于Quotient以往收购的GE Amersham的放射合成业务。...

View Article

Image may be NSFW.
Clik here to view.

NAMSAが滅菌保証製品部門の売却を発表

  米オハイオ州ノースウッド (ビジネスワイヤ) — 世界一流の医学研究組織(MRO®)である北米科学協会(NAMSA)は本日、バイオロジカルインジケーターおよびケミカルインジケーターの滅菌保証製品部門を売却する正式契約を発表しました。患者、ケア提供者、その他の医療提供者向けの革新的な感染予防製品の提供に専心するクロステックス...

View Article

Image may be NSFW.
Clik here to view.

Mitsubishi Electric Develops High-precision Air-quality Sensor for PM2.5

  TOKYO Mitsubishi Electric Corporation (TOKYO:6503) announced today that it has developed a small, high-precision air-quality sensor, the world first to detect all fine particles measuring no more...

View Article

Image may be NSFW.
Clik here to view.

新しい臨床試験でマシモの予備酸素摂量指数は小児患者における切迫した酸素飽和度低下の発見で臨床医に貢献

  スイス・ヌーシャテル (ビジネスワイヤ) — マシモ(NASDAQ: MASI)は本日、新しい臨床試験でマシモの予備酸素摂量指数(Oxygen Reserve...

View Article


Image may be NSFW.
Clik here to view.

AmpliPhi Biosciences Announces Award of Federal Research Grant from Australia...

  SAN DIEGO & SYDNEY AmpliPhi Biosciences Corporation (NYSEMKT:APHB), a global leader in developing bacteriophage-based antibacterial therapies to treat drug-resistant infections, congratulates...

View Article

Image may be NSFW.
Clik here to view.

Cigna Foundation Makes Workplace Wellness a Global Priority; Announces World...

  BLOOMFIELD, Conn. The Cigna Foundation today announced it is making Workplace Wellness a priority for its World of Difference grants outside the United States. Prioritizing Workplace Wellness is a...

View Article


Image may be NSFW.
Clik here to view.

クインタイルズが2016年リーダーシップエクセレンス賞を受賞

Smart Multimedia Gallery   ビデオタイトル QuickTimeで再生 WindowsMediaで再生 米ノースカロライナ州リサーチ・トライアングル・パーク (ビジネスワイヤ)– 世界最大のバイオ製薬サービス企業のクインタイルズは、HR.comから「リーダーシッププログラムの導入における革新」において、2016年リーダーシップエクセレンス賞を授与されました。 このSmart...

View Article

Image may be NSFW.
Clik here to view.

FDA’s Arthritis Advisory Committee Recommends Approval of Celltrion’s CT-P13,...

  INCHEON, South Korea Celltrion, a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) Arthritis Advisory Committee recommended approval of all...

View Article


Image may be NSFW.
Clik here to view.

JIUN Launches Sales of Medical Image Management System SonicDICOM’s Latest...

  FUKUOKA, Japan JIUN Corporation has launched sales and availability of version 2.0.0 of its product “SonicDICOM,” an easy-to-install Medical Image Management System, on February 1, 2016. Product...

View Article

Taro Provides Results for December 31, 2015

  HAWTHORNE, N.Y. Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the three and nine months ended December 31, 2015. Quarter...

View Article

Image may be NSFW.
Clik here to view.

FDAの関節炎諮問委員会がインフリキシマブのバイオシミラーとしてセルトリオンが提案しているCT-P13を全適応症で承認するよう勧告

  韓国・仁川...

View Article
Browsing all 5564 articles
Browse latest View live